[1]
2024. Evaluation Of In-vitro Efficacy Of Betalactam/Non Betalactam Antimicrobials Against ESBL Genotypes from Wound Infection. International Journal of Pharmaceutical Sciences and Drug Research. 16, 3 (May 2024), 302–307. DOI:https://doi.org/10.25004/IJPSDR.2024.160301.